Improving Access to Essential Cardiovascular Medicines
The Center for Global Cardiovascular Health aims to improve access to essential cardiovascular medicines by working through the World Health Organization and national model lists of essential medicines. Dr. Mark Huffman has contributed through the addition of clopidogrel and direct oral anticoagulants to the World Health Organization list of essential medicines, among other changes. An independent study course is offered through the Program in Public Health for students to develop and submit applications to the World Health Organization’s list of essential medicines on a biennial basis.
Northwestern Faculty
Partners
Sandeep Kishore, MD, PhD, MS, Arnold Institute at the Icahn School of Medicine at Mount Sinai
Related Publications
- Kishore SP, Blank E, Heller DJ, Patel A, Peters A, Price M, Vidula M, Fuster V, Onuma O, Huffman MD, Vedanthan R. Modernizing the World Health Organization List of Essential Medicines for preventing and controlling cardiovascular diseases. J Am Coll Cardiol. 2018 Feb 6;71(5):564-574. doi: 10.1016/j.jacc.2017.11.056. Review. PubMed PMID: 29406862.
- Patel A, Vidula M, Kishore SP, Vedanthan R, Huffman MD. Building the case for clopidogrel as a World Health Organization essential Mmedicine. Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):447-51. doi: 10.1161/CIRCOUTCOMES.115.001866. Epub 2015 Jun 2. Review. PubMed PMID: 26038523; PubMed Central PMCID: PMC4512846.
- Huffman MD, Yusuf S. Polypills: essential medicines for cardiovascular disease secondary prevention? J Am Coll Cardiol. 2014 Apr 15;63(14):1368-70. doi: 10.1016/j.jacc.2013.08.1665. Epub 2014 Feb 19. PubMed PMID: 24561141.
Related Information
- World Health Organization's 21st Model List of Essential Medicines
- Fixed-dose combination antihypertensive medications - The Lancet, July 15, 2019.